Search research articles
Contact Us
Filters
Showing results (91-100 of 173) with videos related to
Page
of 18
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
January 27, 2018
Pioglitazone Therapy of PAX8-PPARγ Fusion Protein Thyroid Carcinoma
Thomas J Giordano, Bryan R Haugen, Steven I Sherman, et al.
American Journal of Surgery
|
November 3, 2024
Long term outcomes after repeat lymph node dissections for persistent or recurrent differentiated thyroid cancer
Martin Jose Barrio, Nikita Pozdeyev, Robert C McIntyre, et al.
Molecular Cancer
|
March 10, 2009
Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression
Joshua P Klopper, Vibha Sharma, Andrew Berenz, et al.
Clinical Endocrinology
|
September 11, 2023
Anthropometric, dietary, and lifestyle factors and risk of advanced thyroid cancer: The NIH-AARP diet and health cohort study
Amanda La Greca, Laura Grau, Jaron Arbet, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 13, 2004
Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids
Bryan R Haugen, Lori Lee Larson, Umarani Pugazhenthi, et al.
International Journal of Cancer
|
April 28, 2005
Tumor-specific changes in mtDNA content in human cancer
Elizabeth Mambo, Aditi Chatterjee, Mingzhao Xing, et al.
The Journal of Biological Chemistry
|
July 13, 2002
Isolation and functional analysis of the mouse RXRgamma1 gene promoter in anterior pituitary cells
Nicole B McDermott, David F Gordon, Cynthia A Kramer, et al.
Thyroid : Official Journal of the American Thyroid Association
|
June 9, 2009
Distinct genetic alterations in the mitogen-activated protein kinase pathway dictate sensitivity of thyroid cancer cells to mitogen-activated protein kinase kinase 1/2 inhibition
Rebecca E Schweppe, Anna A Kerege, Vibha Sharma, et al.
American Journal of Surgery
|
November 26, 2015
A "safe and effective" protocol for management of post-thyroidectomy hypocalcemia
Maria B Albuja-Cruz, Nikita Pozdeyev, Steven Robbins, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 3, 2012
Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer
Jena D French, Gregory R Kotnis, Sherif Said, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 173) with videos related to
Sort By:
Page
of 18
The Journal of Clinical Endocrinology and Metabolism
|
January 27, 2018
Pioglitazone Therapy of PAX8-PPARγ Fusion Protein Thyroid Carcinoma
Thomas J Giordano, Bryan R Haugen, Steven I Sherman, et al.
American Journal of Surgery
|
November 3, 2024
Long term outcomes after repeat lymph node dissections for persistent or recurrent differentiated thyroid cancer
Martin Jose Barrio, Nikita Pozdeyev, Robert C McIntyre, et al.
Molecular Cancer
|
March 10, 2009
Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression
Joshua P Klopper, Vibha Sharma, Andrew Berenz, et al.
Clinical Endocrinology
|
September 11, 2023
Anthropometric, dietary, and lifestyle factors and risk of advanced thyroid cancer: The NIH-AARP diet and health cohort study
Amanda La Greca, Laura Grau, Jaron Arbet, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 13, 2004
Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids
Bryan R Haugen, Lori Lee Larson, Umarani Pugazhenthi, et al.
International Journal of Cancer
|
April 28, 2005
Tumor-specific changes in mtDNA content in human cancer
Elizabeth Mambo, Aditi Chatterjee, Mingzhao Xing, et al.
The Journal of Biological Chemistry
|
July 13, 2002
Isolation and functional analysis of the mouse RXRgamma1 gene promoter in anterior pituitary cells
Nicole B McDermott, David F Gordon, Cynthia A Kramer, et al.
Thyroid : Official Journal of the American Thyroid Association
|
June 9, 2009
Distinct genetic alterations in the mitogen-activated protein kinase pathway dictate sensitivity of thyroid cancer cells to mitogen-activated protein kinase kinase 1/2 inhibition
Rebecca E Schweppe, Anna A Kerege, Vibha Sharma, et al.
American Journal of Surgery
|
November 26, 2015
A "safe and effective" protocol for management of post-thyroidectomy hypocalcemia
Maria B Albuja-Cruz, Nikita Pozdeyev, Steven Robbins, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 3, 2012
Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer
Jena D French, Gregory R Kotnis, Sherif Said, et al.
Page
of 18